Results: 1-14 |
Results: 14
Acquired Pelger-Huet anomaly in association with concomitant tacrolimus and fluconazole therapy following allogeneic bone marrow transplantation
Authors: Gondo, H Okamura, C Osaki, K Shimoda, K Asano, Y Okamura, T
Citation: H. Gondo et al., Acquired Pelger-Huet anomaly in association with concomitant tacrolimus and fluconazole therapy following allogeneic bone marrow transplantation, BONE MAR TR, 26(11), 2000, pp. 1255-1257
Analysis of 500 bone marrow transplants from unrelated donors (UR-BMT) facilitated by the Japan Marrow Donor Program: confirmation of UR-BMT as a standard therapy for patients with leukemia and aplastic anemia
Authors: Kodera, Y Morishima, Y Kato, S Akiyama, Y Sao, H Matsuyama, T Kawa, K Sakamaki, H Nakagawa, S Hirabayashi, N Dohi, H Okamoto, S Hiraoka, A Gondo, H Tsuchida, M O, H Harada, M Asano, S Juji, T Sasazuki, T Takaku, F
Citation: Y. Kodera et al., Analysis of 500 bone marrow transplants from unrelated donors (UR-BMT) facilitated by the Japan Marrow Donor Program: confirmation of UR-BMT as a standard therapy for patients with leukemia and aplastic anemia, BONE MAR TR, 24(9), 1999, pp. 995-1003
A utility of ductography and fiberoptic ductoscopy for patients with nipple discharge
Authors: Yamamoto, D Shoji, T Kawanishi, H Nakagawa, H Haijima, H Gondo, H Tanaka, K
Citation: D. Yamamoto et al., A utility of ductography and fiberoptic ductoscopy for patients with nipple discharge, BREAST CANC, 70(2), 2001, pp. 103-108
Chronic lymphocytic leukemia (CLL) is rare, but the proportion of T-CLL ishigh in Japan
Authors: Tamura, K Sawada, H Izumi, Y Fukuda, T Utsunomiya, A Ikeda, S Uike, N Tsukada, J Kawano, F Shibuya, T Gondo, H Okamura, S Suzumiya, J
Citation: K. Tamura et al., Chronic lymphocytic leukemia (CLL) is rare, but the proportion of T-CLL ishigh in Japan, EUR J HAEMA, 67(3), 2001, pp. 152-157
Decreases in Ikaros activity correlate with blast crisis in patients with chronic myelogenous leukemia
Authors: Nakayama, H Ishimaru, F Avitahl, N Sezaki, N Fujii, N Nakase, K Ninomiya, Y Harashima, A Minowada, J Tsuchiyama, J Imajoh, K Tsubota, T Fukuda, S Sezaki, T Kojima, K Hara, M Takimoto, H Yorimitsu, S Takahashi, I Miyata, A Taniguchi, S Tokunaga, Y Gondo, H Niho, Y Nakao, S Kyo, T Dohy, H Kamada, N Harada, M
Citation: H. Nakayama et al., Decreases in Ikaros activity correlate with blast crisis in patients with chronic myelogenous leukemia, CANCER RES, 59(16), 1999, pp. 3931-3934
Donor leukocyte infusion for Japanese patients with relapsed leukemia after allogeneic bone marrow transplantation: lower incidence of acute graft-versus-host disease and improved outcome
Authors: Shiobara, S Nakao, S Ueda, M Yamazaki, H Takahashi, S Asano, S Yabe, H Kato, S Imoto, S Maruta, A Yoshida, T Gondo, H Morishima, Y Kodera, Y
Citation: S. Shiobara et al., Donor leukocyte infusion for Japanese patients with relapsed leukemia after allogeneic bone marrow transplantation: lower incidence of acute graft-versus-host disease and improved outcome, BONE MAR TR, 26(7), 2000, pp. 769-774
Effect of thrombopoietin on acute myelogenous leukemia blasts
Authors: Tokunaga, Y Miyamoto, T Gondo, H Okamura, T Niho, Y
Citation: Y. Tokunaga et al., Effect of thrombopoietin on acute myelogenous leukemia blasts, LEUK LYMPH, 37(1-2), 2000, pp. 27-37
High-dose chemotherapy with autologous PBSCT as post-remission therapy forAML
Authors: Harada, M Gondo, H Kawano, F
Citation: M. Harada et al., High-dose chemotherapy with autologous PBSCT as post-remission therapy forAML, BONE MAR TR, 27(3), 2001, pp. 347-347
Human thymic epithelial cells maintain long-term survival of clonogenic myeloid and erythroid progenitor cells in vitro
Authors: Takenaka, K Harada, M Fujisaki, T Nagafuji, K Mizuno, S Miyamoto, T Otsuka, T Gondo, H Okamura, T Niho, Y
Citation: K. Takenaka et al., Human thymic epithelial cells maintain long-term survival of clonogenic myeloid and erythroid progenitor cells in vitro, BR J HAEM, 111(1), 2000, pp. 363-370
Immunosuppressive therapy for patients with refractory anemia
Authors: Asano, Y Maeda, M Uchida, N Yokoyama, T Osaki, K Shimoda, K Gondo, H Okamura, T Okamura, S Niho, Y
Citation: Y. Asano et al., Immunosuppressive therapy for patients with refractory anemia, ANN HEMATOL, 80(11), 2001, pp. 634-638
Lamivudine therapy for a hepatitis B surface antigen (HBsAg)-positive leukemia patient receiving myeloablative chemotherapy and autologous stem cell transplantation
Authors: Uchida, N Gondo, H Himeji, D Kaji, Y Sata, M Niho, Y
Citation: N. Uchida et al., Lamivudine therapy for a hepatitis B surface antigen (HBsAg)-positive leukemia patient receiving myeloablative chemotherapy and autologous stem cell transplantation, BONE MAR TR, 26(11), 2000, pp. 1243-1245
MLL gene rearrangement in t(9;11) acute myelogenous leukemia with minimal myeloid differentiation (FAB subtype M0)
Authors: Shimoda, K Sugio, Y Miyahara, M Watanabe, K Tokunaga, Y Asano, Y Gondo, H Okamura, T Niho, Y
Citation: K. Shimoda et al., MLL gene rearrangement in t(9;11) acute myelogenous leukemia with minimal myeloid differentiation (FAB subtype M0), INT J HEMAT, 71(3), 2000, pp. 245-248
Multiple autoimmune haemopoietic disorders and insidious clonal proliferation of large granular lymphocytes
Authors: Akashi, K Shibuya, T Taniguchi, S Hayashi, S Iwasaki, H Teshima, T Takamatsu, Y Gondo, H Okamura, T Harada, M Niho, Y
Citation: K. Akashi et al., Multiple autoimmune haemopoietic disorders and insidious clonal proliferation of large granular lymphocytes, BR J HAEM, 107(3), 1999, pp. 670-673
Tyk2 plays a restricted role in IFN alpha signaling, although it is required for IL-12-mediated T cell function
Authors: Shimoda, K Kato, K Aoki, K Matsuda, T Miyamoto, A Shibamori, M Yamashita, M Numata, A Takase, K Kobayashi, S Shibata, S Asano, Y Gondo, H Sekiguchi, K Nakayama, K Nakayama, T Okamura, T Okamura, S Niho, Y Nakayama, K
Citation: K. Shimoda et al., Tyk2 plays a restricted role in IFN alpha signaling, although it is required for IL-12-mediated T cell function, IMMUNITY, 13(4), 2000, pp. 561-571
Risultati: 1-14 |